CompletedNot Applicable

Contribution of Drug Induced Sleep Endoscopy of Pediatric Obstructive Sleep Apnea Hypopnea Syndrome

France31 participantsStarted 2015-10-01

Plain-language summary

The role of drug-induced sleep endoscopy (DISE) in the management of obstructive sleep apnea hypopnea syndrome (OSAHS) is not precisely defined for children. The primary objective of this study was to describe the consequences of DISE in the therapeutic management for children with OSAHS. The secondary objectives were to analyze the correlation between the number of obstructive sites found during DISE, the value of apnea-hypopnea index (AHI), and the type of OSAHS.

Who can participate

Age range12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: \- OSAHS confirmed by overnight sleep monitoring (respiratory polygraphy or overnight polysomnography) Exclusion criteria: \- Lack of data

What they're measuring

sleep endoscopy

Timeframe: 1 day

Trial details

NCT IDNCT03845062

SponsorUniversity Hospital, Montpellier

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-06-01

View on ClinicalTrials.gov More Obstructive Sleep Apnea Hypopnea Syndrome trials